ReviewBioactive materials2027
Lifecycle tissue engineering: An AI-enabled multimodal sensing and digital twin roadmap.
Review in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical translation of tissue engineering (TE) is critically hampered by the absence of real-time, non-invasive monitoring throughout the entire lifecycle of tissue fabrication and repair. Current reliance on end-point assessments obscures dynamic biological events, making early detection of deviations and failures challenging. While multimodal sensing offers rich data streams, inherent issues such as long-term drift, noise accumulation, and difficulties in cross-modality comparability impede their transformation into reliable process metrics and actionable insights. This review introduces a novel, comprehensive four-layer framework consisting of Problem, Data, Model, and Application Evidence, to systematically integrate artificial intelligence (AI)-enabled multimodal sensing across the full TE lifecycle. The Problem Layer delineates critical biological uncertainties and monitoring requirements. The Data Layer surveys diverse
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.